Advance Zinctek Limited has released a press release.
FY26 Unaudited Profit Before Tax Up 13% on Prior Year
Earlier from Advance Zinctek
- Zinc Oxide 100% exempt from Pharmaceutical Tariifs
- Appendix 4D
- Chair's Presentation to Shareholders
- Improvement of 26.83% in First Quarter Revenue - FY26